Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Report Code: PHM046D

Publish Date: Apr 2024

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Report Includes

  • 43 data tables and 66 additional tables
  • An overview of the global markets for gastrointestinal disease (GI) therapeutics and diagnostics.
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
  • Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
  • Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
  • Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
  • A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
  • Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies’ ESG scores, and the ESG practices followed by leading companies.
  • Information pertaining to the recent developments and emerging technologies in the market.
  • Review of current and potential treatment options and their impact on this market growth.
  • A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
  • An analysis of the competitive landscape based on recent developments and segmental revenues.
  • Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.

Report Scope

This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $86.0 billion
Market size forecast $122.5 billion
Growth rate CAGR of 7.3% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Drug Type, Disease Type, Product Type, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Key Market Drivers
  • Increasing prevalence of GI disorders and cancer.
  • Growing trend toward screening and preventive care.
  • Growing adoption and approval of biological drugs.
  • High unmet need.
Companies studied
ABBVIE INC.BAYER AG
BOSTON SCIENTIFIC CORP.BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.GSK PLC.
HALEON GROUP OF CO.JOHNSON & JOHNSON SERVICES INC.
OLYMPUS CORP.PROCTER & GAMBLE
SANOFITAKEDA PHARMACEUTICAL CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global GI therapeutics and diagnostics market was estimated to be around $86.0 billion in 2023. The market is projected to reach $122.5 billion in 2028, growing at a CAGR of 7.3% during the forecast period.
An in-depth analysis of the global GI therapeutics and diagnostics market, including historical data and market projection on sales by product type and subtypes, and region.
By product type, prescription (Rx) GI therapies segment is anticipated to dominate the market by the end of 2028.
Prescription (Rx) GI therapies is the fastest growing market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets132Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview 2Free
Chapter- 3: Market Dynamics 8Free
Chapter- 4: Emerging Technologies and Developments 4Free
Chapter- 5: Market Segmentation Analysis62Free
Chapter- 6: Competitive Intelligence7Free
Chapter- 7: Appendix46Free
Published - Sep-2016| Analyst - Yogita Zutshi| Code - PHM046C

Report Highlights

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

Report Includes

  • An overview of the global markets for gastrointestinal therapeutics and diagnostics. 
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
  • Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.
Published - Sep-2009| Analyst - Mary Anne Crandall| Code - PHM046B

Report Highlights

  • Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.
  • The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Published - Sep-2005| Analyst - Mary Anne Crandall| Code - PHM046A

Report Highlights

  • The total U.S. market for gastrointestinal disorder treatments was estimated at $16.1 billion for 2004. Rising at an AAGR (average annual growth rate) of 7.3%, the market is expected to reach $22.8 billion in 2009.
  • The prescription market accounted for the largest percentage of sales with approximately 85%, or $13.7 billion in sales in for 2004. This segment is also rising the fastest, with an AAGR of 7.7%.
  • The OTC market accounts for the remaining 15%, or $2.4 billion. Rising at AAGR of 14%, it will represent only 13% of the market in 2009.
  • At approximately 80%, the largest area of market participation for leading competitors is within the prescription drug segment.

Related Reports

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Global Bronchoscopy Market

Published - Oct 2023 | Publisher - BCC Publishing | Code - MDS097A

The global bronchoscopy market should reach $3.9 billion by 2028 from $2.7 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028.

Endoscopy Devices: Applications and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - HLC093E

The global market for endoscopy devices is estimated to increase from $51.7 billion in 2022 to reach $75.9 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Global Markets for Infectious Disease Treatments

Published - Jan 2022 | Publisher - BCC Publishing | Code - PHM061E

The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.

Recent Reports

Softgel Capsules: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM244B

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Active Pharmaceutical Ingredients: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM200C

The global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Global Market for Contract Research Organization (CRO) Services

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM186C

The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
Sample Report